|
US5244792A
(en)
|
1984-04-06 |
1993-09-14 |
Chiron Corporation |
Expression of recombinant glyoprotein B from herpes simplex virus
|
|
JPH0668B2
(ja)
|
1985-08-30 |
1994-01-05 |
財団法人化学及血清療法研究所 |
単純ヘルペスウイルス遺伝子が組込まれた組換えプラスミド
|
|
GB8918616D0
(en)
|
1989-08-15 |
1989-09-27 |
Univ Glasgow |
Herpes simplex virus type 1 mutant
|
|
US5725871A
(en)
|
1989-08-18 |
1998-03-10 |
Danbiosyst Uk Limited |
Drug delivery compositions comprising lysophosphoglycerolipid
|
|
US5707644A
(en)
|
1989-11-04 |
1998-01-13 |
Danbiosyst Uk Limited |
Small particle compositions for intranasal drug delivery
|
|
US5466468A
(en)
|
1990-04-03 |
1995-11-14 |
Ciba-Geigy Corporation |
Parenterally administrable liposome formulation comprising synthetic lipids
|
|
US5849572A
(en)
|
1990-10-10 |
1998-12-15 |
Regents Of The University Of Michigan |
HSV-1 vector containing a lat promoter
|
|
US5849571A
(en)
|
1990-10-10 |
1998-12-15 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Latency active herpes virus promoters and their use
|
|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
US5756353A
(en)
|
1991-12-17 |
1998-05-26 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol-and liposome-based delivery
|
|
ATE155681T1
(de)
|
1992-05-18 |
1997-08-15 |
Minnesota Mining & Mfg |
Einrichtung zur transmucosalen wirkstoffabgabe
|
|
US5879934A
(en)
|
1992-07-31 |
1999-03-09 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Herpes simplex virus strains for gene transfer
|
|
US5658724A
(en)
|
1992-07-31 |
1997-08-19 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Herpes simplex virus strains deficient for the essential immediate early genes ICP4 and ICP27 and methods for their production, growth and use
|
|
US5804413A
(en)
|
1992-07-31 |
1998-09-08 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Herpes simplex virus strains for gene transfer
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
GB9415319D0
(en)
|
1994-07-29 |
1994-09-21 |
Medical Res Council |
HSV viral vector
|
|
GB9415369D0
(en)
|
1994-07-29 |
1994-09-21 |
Lynxvale Ltd |
Mutant virus
|
|
IE80468B1
(en)
|
1995-04-04 |
1998-07-29 |
Elan Corp Plc |
Controlled release biodegradable nanoparticles containing insulin
|
|
US6261552B1
(en)
|
1997-05-22 |
2001-07-17 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Herpes simplex virus vectors
|
|
GB9700411D0
(en)
|
1997-01-10 |
1997-02-26 |
Univ London |
Eukaryotic gene expression cassette and uses thereof
|
|
US6071742A
(en)
|
1997-03-05 |
2000-06-06 |
Board Of Regents Of The University Of Nebraska |
Coxsackie virus as a vector for delivery of anti-inflammatory cytokines
|
|
US5998174A
(en)
|
1997-05-12 |
1999-12-07 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Multigene vectors
|
|
EP1002119A1
(en)
|
1997-07-31 |
2000-05-24 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Targeted hsv vectors
|
|
WO1999031241A1
(en)
|
1997-12-17 |
1999-06-24 |
Immunex Corporation |
Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides
|
|
GB9810423D0
(en)
|
1998-05-15 |
1998-07-15 |
Cancer Res Campaign Tech |
Ionizing radiation or diathermy-switched gene therapy vectors and their use in antitumour therapy
|
|
EP1002864A1
(en)
|
1998-11-10 |
2000-05-24 |
Universita' degli studi di Bologna |
HIgR and related V domain for the manufacture of a medicament for preventing or treating HSV-1, HSV-2 and BHV infections
|
|
US6897057B1
(en)
|
1999-08-31 |
2005-05-24 |
The General Hospital Corporation |
Cell-specific and/or tumor-specific promoter retargeting of herpes γ 34.5 gene expression
|
|
GB9930418D0
(en)
|
1999-12-22 |
2000-02-16 |
Neurovex Ltd |
Replication incompetent herpes virus vectors
|
|
EP1381280B1
(en)
|
2001-03-27 |
2011-05-11 |
Catherex, Inc. |
Viral vectors and their use in therapeutic methods
|
|
US20020187126A1
(en)
|
2001-04-06 |
2002-12-12 |
Mount Sinai School Of Medicine |
Methods for viral oncoapoptosis in cancer therapy
|
|
JP2005523681A
(ja)
|
2001-10-04 |
2005-08-11 |
イミュネックス・コーポレーション |
Ul16結合タンパク質4
|
|
KR100900249B1
(ko)
|
2001-12-07 |
2009-05-29 |
포항공과대학교 산학협력단 |
SIVmac239의 면역원성 플라스미드 및 이들을 함유한AIDS DNA 백신
|
|
AU2003216502B2
(en)
|
2002-03-01 |
2008-04-10 |
Sloan-Kettering Institute For Cancer Research |
Prevention of recurrence and metastasis of cancer
|
|
US8927251B2
(en)
|
2002-10-07 |
2015-01-06 |
The University Of Chicago |
Targeting of herpes simplex virus to specific receptors
|
|
EP2434020B1
(en)
|
2004-01-22 |
2014-11-05 |
Dnavec Research Inc. |
Method of producing Paramyxoviridae viral vectors using a hybrid promoter comprising a cytomegalovirus enhancer and a chicken beta-actin promoter
|
|
GB0406389D0
(en)
|
2004-03-22 |
2004-04-21 |
Istituto Superiore Di Sanito |
Recombinant herpes simplex virus and uses therefor
|
|
US7473418B2
(en)
|
2004-03-25 |
2009-01-06 |
Cell Genesys, Inc. |
Pan cancer oncolytic vectors and methods of use thereof
|
|
KR101295733B1
(ko)
|
2004-08-20 |
2013-08-13 |
비랄리틱스 리미티드 |
혈액암의 치료방법 및 조성물
|
|
WO2006050211A2
(en)
|
2004-10-28 |
2006-05-11 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain
|
|
CN102166218A
(zh)
|
2005-01-17 |
2011-08-31 |
溶瘤病毒有限公司 |
治疗肿瘤的方法和组合物
|
|
DK2002003T3
(en)
*
|
2005-05-27 |
2016-03-21 |
Ospedale San Raffaele Srl |
Gene vector comprising miRNA
|
|
EP2325332B1
(en)
|
2005-08-26 |
2012-10-31 |
DuPont Nutrition Biosciences ApS |
Use of CRISPR associated genes (CAS)
|
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
|
US20080008686A1
(en)
|
2006-07-10 |
2008-01-10 |
The Brigham And Women's Hospital, Inc. |
Tetracycline repressor regulated oncolytic viruses
|
|
JP2010500029A
(ja)
|
2006-08-11 |
2010-01-07 |
ダウ アグロサイエンシィズ エルエルシー |
ジンクフィンガーヌクレアーゼ媒介相同組換え
|
|
EP2125032A4
(en)
|
2007-02-20 |
2011-02-23 |
Mayo Foundation |
CANCER TREATMENT WITH VIRAL NUCLEIC ACID
|
|
CA2687301C
(en)
|
2007-05-09 |
2016-08-23 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Synthetic herpes simplex viruses type-1 for treatment of cancers
|
|
WO2008143875A1
(en)
|
2007-05-14 |
2008-11-27 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Targeted delivery of glycine receptors to excitable cells
|
|
WO2009111892A1
(en)
|
2008-03-14 |
2009-09-17 |
Ottawa Health Research Institute |
Microrna mediated oncolytic targeting
|
|
GB0807424D0
(en)
|
2008-04-23 |
2008-05-28 |
Isis Innovation |
Virus
|
|
NO2700405T3
(cg-RX-API-DMAC7.html)
|
2008-05-29 |
2018-09-01 |
|
|
|
WO2009148488A2
(en)
|
2008-05-29 |
2009-12-10 |
The General Hospital Corporation |
Use of oncolytic herpes viruses for killing cancer stem cells
|
|
GB0810912D0
(en)
|
2008-06-13 |
2008-07-23 |
Inst Animal Health Ltd |
Vector
|
|
US8546553B2
(en)
|
2008-07-25 |
2013-10-01 |
University Of Georgia Research Foundation, Inc. |
Prokaryotic RNAi-like system and methods of use
|
|
US20100076057A1
(en)
|
2008-09-23 |
2010-03-25 |
Northwestern University |
TARGET DNA INTERFERENCE WITH crRNA
|
|
WO2010054108A2
(en)
|
2008-11-06 |
2010-05-14 |
University Of Georgia Research Foundation, Inc. |
Cas6 polypeptides and methods of use
|
|
DK2362915T3
(en)
|
2008-11-07 |
2017-03-27 |
Dupont Nutrition Biosci Aps |
CRISPR SEQUENCES OF BIFIDOBACTERIA
|
|
CA2755245A1
(en)
|
2009-03-13 |
2010-09-16 |
Egen, Inc. |
Compositions and methods for the delivery of biologically active rnas
|
|
US20100297072A1
(en)
|
2009-05-19 |
2010-11-25 |
Depinho Ronald A |
Combinations of Immunostimulatory Agents, Oncolytic Virus, and Additional Anticancer Therapy
|
|
WO2011119925A2
(en)
|
2010-03-25 |
2011-09-29 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Synthetic herpes simplex viruses for treatment of cancers
|
|
JP5652830B2
(ja)
|
2010-04-09 |
2015-01-14 |
国立大学法人 東京大学 |
マイクロrna制御組換えワクシニアウイルス及びその使用
|
|
WO2011130749A2
(en)
|
2010-04-16 |
2011-10-20 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-hsv receptors
|
|
WO2012006181A2
(en)
|
2010-06-29 |
2012-01-12 |
Mount Sinai School Of Medicine |
Compositions and methods for inhibiting oncogenic micrornas and treatment of cancer
|
|
DK2630156T3
(en)
|
2010-10-20 |
2018-12-17 |
Dupont Nutrition Biosci Aps |
CRISPR-CAS SEQUENCES OF LACTOCOCCUS
|
|
CA2834375C
(en)
|
2011-04-27 |
2020-07-14 |
Amyris, Inc. |
Methods for genomic modification
|
|
US20140113376A1
(en)
|
2011-06-01 |
2014-04-24 |
Rotem Sorek |
Compositions and methods for downregulating prokaryotic genes
|
|
EP2543734A1
(en)
|
2011-07-07 |
2013-01-09 |
Deutsches Krebsforschungszentrum |
Adeno-parvovirus chimera with enhanced oncolytical potential
|
|
EP2591796A1
(en)
|
2011-11-10 |
2013-05-15 |
Universität Zürich |
Combination medicament comprising IL-12 and an anti-CTLA-4 ligand for tumor therapy
|
|
PL3351261T3
(pl)
|
2011-10-11 |
2021-12-06 |
Universität Zürich |
Lek złożony zawierający IL-12 i środek do blokowania cząsteczek hamujących komórki T w terapii nowotworów
|
|
US11951157B2
(en)
|
2011-10-11 |
2024-04-09 |
Universitat Zurich |
Methods of treating malignant tumour with IL-12 and anti-PD-1 antibody
|
|
US20130156808A1
(en)
|
2011-11-22 |
2013-06-20 |
Stipan Jonjic |
Vaccine comprising beta-herpesvirus
|
|
GB201122458D0
(en)
|
2011-12-30 |
2012-02-08 |
Univ Wageningen |
Modified cascade ribonucleoproteins and uses thereof
|
|
US20140363469A1
(en)
*
|
2012-01-19 |
2014-12-11 |
Alnylam Pharmaceuticals, Inc. |
Viral attenuation and vaccine production
|
|
EP2836226B1
(en)
|
2012-02-24 |
2017-06-28 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for the treatment of hemoglobinopathies
|
|
US9637739B2
(en)
|
2012-03-20 |
2017-05-02 |
Vilnius University |
RNA-directed DNA cleavage by the Cas9-crRNA complex
|
|
WO2013141680A1
(en)
|
2012-03-20 |
2013-09-26 |
Vilnius University |
RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
|
|
JP6605957B2
(ja)
|
2013-01-04 |
2019-11-13 |
シトムクス セラピューティクス,インコーポレイティド |
生体系におけるプロテアーゼ活性を検出するための組成物及び方法
|
|
KR20250012194A
(ko)
|
2013-06-17 |
2025-01-23 |
더 브로드 인스티튜트, 인코퍼레이티드 |
바이러스 구성성분을 사용하여 장애 및 질환을 표적화하기 위한 crispr-cas 시스템 및 조성물의 전달, 용도 및 치료 적용
|
|
JP6726824B2
(ja)
|
2013-07-17 |
2020-07-22 |
ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション |
効率的な遺伝子送達用途のための非毒性hsvベクター及びその製造のための補完細胞
|
|
DK3184641T3
(da)
|
2013-10-28 |
2020-08-03 |
Univ Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Onkolytisk hsv-vektor
|
|
AU2015222685A1
(en)
|
2014-02-27 |
2016-09-08 |
Viralytics Limited |
Combination method for treatment of cancer
|
|
CN107073090A
(zh)
*
|
2014-04-30 |
2017-08-18 |
哈佛学院董事会 |
结合的疫苗装置和杀死癌细胞的方法
|
|
DK3552615T3
(da)
|
2014-07-16 |
2022-02-14 |
Transgene |
Onkolytisk virus til ekspression af immun-checkpoint-modulatorer
|
|
EP3268034A4
(en)
|
2015-03-05 |
2018-11-14 |
Northwestern University |
Non-neuroinvasive viruses and uses thereof
|
|
US10083137B2
(en)
|
2015-04-02 |
2018-09-25 |
Atmel Corporation |
Peripheral interface circuit for serial memory
|
|
US9884704B2
(en)
|
2015-08-04 |
2018-02-06 |
Ernesto A. Aguero-Hernandez |
Clip-clamp with top lock device and method
|
|
US10210575B1
(en)
|
2015-08-12 |
2019-02-19 |
State Farm Mutual Automobile Insurance Company |
System and method of using an image object as a visual data container
|
|
SG10201913573UA
(en)
*
|
2015-10-01 |
2020-03-30 |
Heat Biologics Inc |
Compositions and methods for adjoining type i and type ii extracellular domains as heterologous chimeric proteins
|
|
JP6954648B2
(ja)
|
2015-10-19 |
2021-10-27 |
シージー オンコロジー, インコーポレイテッド |
併用療法による固形腫瘍又はリンパ系腫瘍の治療方法
|
|
WO2017096201A1
(en)
|
2015-12-02 |
2017-06-08 |
Memorial Sloan-Kettering Cancer Center |
Seneca valley virus (svv) cellular receptor targeted oncotherapy
|
|
US11155622B2
(en)
*
|
2015-12-17 |
2021-10-26 |
Psioxus Therapeutics Limited |
Virus encoding an anti-TCR-complex antibody or fragment
|
|
EP3400291B2
(en)
|
2016-01-08 |
2024-02-28 |
Replimune Limited |
Engineered virus
|
|
AU2017212713B2
(en)
|
2016-01-27 |
2023-01-19 |
Oncorus, Inc. |
Oncolytic viral vectors and uses thereof
|
|
US11497781B2
(en)
|
2016-03-10 |
2022-11-15 |
Cg Oncology, Inc. |
Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus CG0070 and an immune checkpoint inhibitor
|
|
KR102323872B1
(ko)
|
2016-04-22 |
2021-11-08 |
임비라 컴퍼니 리미티드 |
암치료용 종양 용해성 단순 헤르페스 바이러스(oHSV) 절대 벡터 및 그 구조체의 구조
|
|
MX2018015542A
(es)
|
2016-06-14 |
2019-10-14 |
Univ Pittsburgh Commonwealth Sys Higher Education |
Expresion de proteinas de ligando activadoras de nkg2d para la sensibilizacion de celulas cancerosas para el ataque por celulas inmunocitotoxicas.
|
|
EP3478321A4
(en)
*
|
2016-06-30 |
2020-04-22 |
Oncorus, Inc. |
PSEUDOTYPIZED ONCOLYTIC VIRAL ADMINISTRATION OF THERAPEUTIC POLYPEPTIDES
|
|
CA3032669A1
(en)
|
2016-08-01 |
2018-02-08 |
William Jia |
Oncolytic herpes simplex virus vectors expressing immune system-stimulatory molecules
|
|
CN110050062A
(zh)
|
2016-08-09 |
2019-07-23 |
阿尔莫哈纳德·阿尔卡亚尔 |
表达il12的溶瘤弹状病毒
|
|
KR102491752B1
(ko)
*
|
2016-08-29 |
2023-01-26 |
싸이오서스 테라퓨틱스 엘티디. |
이중특이성 T 세포 세포 관여자(BiTE)가 보강된 아데노바이러스
|
|
TW201825511A
(zh)
|
2016-09-09 |
2018-07-16 |
美商艾斯合顧問有限公司 |
表現免疫檢查點調節子的溶瘤病毒
|
|
EP3534923A4
(en)
|
2016-11-01 |
2020-05-27 |
DNAtrix, Inc. |
COMBINATION THERAPY FOR THE TREATMENT OF BRAIN CARCINOMAS
|
|
US11298420B2
(en)
|
2016-12-21 |
2022-04-12 |
Memgen, Llc |
Armed oncolytic viruses
|
|
WO2018118967A1
(en)
|
2016-12-21 |
2018-06-28 |
Memgen, Llc |
Armed replication-competent oncolytic adenoviruses
|
|
GB201700350D0
(en)
|
2017-01-09 |
2017-02-22 |
Replimune Ltd |
Altered virus
|
|
RU2020106730A
(ru)
|
2017-07-14 |
2021-08-16 |
Онкорус, Инк. |
Инкапсулированные полинуклеотиды и способы их применения
|
|
MX2020000993A
(es)
|
2017-07-26 |
2020-07-22 |
Oncorus Inc |
Vectores virales oncolíticos y usos de estos.
|
|
EP3875119A4
(en)
|
2018-10-30 |
2022-08-31 |
The University of Tokyo |
ONCOLYTIC VIRUS FOR CANCER THERAPY
|
|
WO2020186356A1
(en)
|
2019-03-20 |
2020-09-24 |
Turnstone Biologics Inc. |
Methods for inducing an immune response against neoantigens
|
|
US20220152168A1
(en)
|
2019-03-20 |
2022-05-19 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Sequential heterologous boost oncolytic viral immunotherapy
|
|
CN114765990A
(zh)
|
2019-10-10 |
2022-07-19 |
昂克诺斯公司 |
双重病毒和双重溶瘤病毒以及治疗方法
|
|
EP4061951A4
(en)
|
2019-11-18 |
2024-03-13 |
The Brigham & Women's Hospital, Inc. |
CODON-OPTIMIZED NEW GENERATION OF REGULAtable FUSOGENIC ONCOLYTIC VIRUSES OF HERPES SIMPLEX VIRUS TYPE 1 AND METHOD OF USE
|